FDA Proposes Changes to Over-the-Counter Bronchodilator Drug Products

Summary

The Food and Drug Administration (FDA) is proposing to update the labeling of over-the-counter bronchodilator medications to include additional warnings and revised instructions, affecting products containing certain ingredients such as ephedrine and epinephrine.